An opportunity to improve access to care, quality of care

GKD was born out of diagnostic obstacles observed by our founder, Brianna Wronko, during her time working in a local HIV clinic. Brianna encountered a pregnant mother diagnosed with HIV. Her liver function and viral load counts were tested, but during the wait time for results, the mother left the clinic. By the time she returned six months later, her condition had developed and lead to extensive physical obstacles for both her and her child.

Brianna realized this wasn’t a unique case; patients were constantly being lost with their health conditions worsening in the long wait times prior to diagnostic follow-ups. That’s if patients were able to secure access to care in the first place. To solve this problem, Brianna founded GKD and led the development of our flagship product platform, the MultiNostic. GKD has received widespread support and funding to accomplish her vision of improving the quality of care, and expanding access to that care.


A point-of-care that gets to the point of care

Our mission is to overhaul the diagnostic process, improve the quality of care for patients and ease the administrative burden on physicians. Since the invention of the MultiNostic, GKD is poised to bring disruptive, rapid diagnostic testing solutions to market.

We have plans for more than 40 diagnostic and screening tests including liver function, comprehensive metabolic panel, complete blood count, thyroid function, STI testing, viral loads and bacterial identification.

We’re committed to maximizing the far-reaching potential the MultiNostic has to revolutionize point-of-care testing.